Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Preclinical data suggest NXD-30001 may hold promise to treat ALS

Dec. 22, 2010

LY-2784544 inhibits V617F-mutant JAK-2 signaling and advances through clinical development

Dec. 22, 2010

Acceleron Pharma's ACE-536 increases red blood cells in vivo

Dec. 22, 2010

MRx-102 shows promise in models of AML

Dec. 21, 2010

NS-018 preferentially targets V617F-mutant JAK2

Dec. 21, 2010

Clinical and preclinical data presented on GDC-0941/T-DM1 in HER2+ breast cancer

Dec. 21, 2010

Panobinostat/capecitabine/lapatinib combination is safe in HER2+ breast cancer

Dec. 21, 2010

CK-2017357 leads to functional improvement in ALS

Dec. 20, 2010

MM-302 shows promise to treat HER2-overexpressing tumors

Dec. 20, 2010

Simvastatin may stabilize visual field in normal-tension glaucoma

Dec. 20, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...